The Review of the National Medicines Policy (NMP) has been commissioned in recognition of the substantial changes to the health landscape since the policy was published in 2000.  An Expert Advisory Committee has been appointed to lead the Review and this Committee is now welcoming submissions to inform the Review of the NMP.  

A Discussion Paper has been prepared to provide context for the Review, and to encourage consideration of the issues the Review could address. The Paper includes a series of questions to help guide your feedback.  Submissions can be lodged at the Review of the NMP Public Consultation page. Members are encouraged to make an individual submission if they wish to do so. 

The call for submissions closes on Friday 8 October 2021.